Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of signing consent forms
- People who have been diagnosed with, or are suspected to have, one of the following conditions: a protein abnormality in the blood called MGUS (Monoclonal Gammopathy of Undetermined Significance), smoldering multiple myeloma (an early, inactive form of multiple myeloma), multiple myeloma (a type of blood cancer affecting plasma cells), a tumour made of plasma cells in the bone or soft tissue (plasmacytoma), or a condition where abnormal proteins build up in organs and tissues (primary amyloidosis)
Who may not be able to join:
- People who are under 18 years of age
- People who have not been diagnosed with, and are not suspected to have, any of the conditions listed above (MGUS, smoldering multiple myeloma, multiple myeloma, plasmacytoma, or primary amyloidosis)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Attaya Suvannasankha, MD, Indiana University
Phone: 317-274-0843
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Create a repository
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.